Apixaban Compared With Warfarin for Stroke Prevention in Atrial Fibrillation Implications of Time in Therapeutic Range

被引：11
|
作者：
Gallego, Pilar [1 ,2 ]
Antonio Vilchez, Juan [1 ,3 ,4 ]
Lane, Deirdre A. [1 ]
机构：
[1] Univ Birmingham, City Hosp, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
[2] Morales Meseguer Univ Hosp, Dept Hematol & Clin Oncol, Murcia, Spain
[3] Hosp Univ Virgen de la Arrixaca, Dept Cardiol, Murcia, Spain
[4] Hosp Univ Virgen de la Arrixaca, Dept Clin Anal, Murcia, Spain
来源：
CIRCULATION | 2013年 / 127卷 / 22期
关键词：
Editorials; anticoagulants; apixaban; atrial fibrillation; time in therapeutic range; warfarin; NORMALIZED RATIO CONTROL; ANTICOAGULATION CONTROL; ORAL ANTICOAGULANT; EFFICACY; OUTCOMES; QUALITY; SAFETY;
D O I：
10.1161/CIRCULATIONAHA.113.003132
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2163 / 2165
页数：3
相关论文
共 50 条
  • [1] The importance of time in therapeutic range of warfarin for stroke prevention in atrial fibrillation
    Chao, Tze-Fan
    Liu, Chih-Min
    Liao, Jo -Nan
    KARDIOLOGIA POLSKA, 2023, 81 (02) : 105 - 106
  • [2] Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
    Jansson, M.
    Sjalander, S.
    Sjogren, V
    Bjorck, F.
    Renlund, H.
    Norrving, B.
    Sjalander, A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2023, 55 (03) : 415 - 425
  • [3] Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation
    Wallentin, Lars
    Lopes, Renato D.
    Hanna, Michael
    Thomas, Laine
    Hellkamp, Anne
    Nepal, Sunil
    Hylek, Elaine M.
    Al-Khatib, Sana M.
    Alexander, John H.
    Alings, Marco
    Amerena, John
    Ansell, Jack
    Aylward, Philip
    Bartunek, Jozef
    Commerford, Patrick
    De Caterina, Raffaele
    Erol, Cetin
    Harjola, Veli-Pekka
    Held, Claes
    Horowitz, John D.
    Huber, Kurt
    Husted, Steen
    Keltai, Matyas
    Lanas, Fernando
    Liu Lisheng
    McMurray, John J. V.
    Oh, Byung-Hee
    Rosenqvist, Marten
    Ruzyllo, Witold
    Steg, Philippe Gabriel
    Vinereanu, Dragos
    Xavier, Denis
    Granger, Christopher B.
    CIRCULATION, 2013, 127 (22) : 2166 - +
  • [4] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Lip, Gregory Y. H.
    Lanitis, Tereza
    Kongnakorn, Thitima
    Phatak, Hemant
    Chalkiadaki, Corina
    Liu, Xianchen
    Kuznik, Andreas
    Lawrence, Jack
    Dorian, Paul
    CLINICAL THERAPEUTICS, 2015, 37 (11) : 2476 - 2488
  • [5] Time-in-therapeutic-range defined warfarin and direct oral anticoagulants in atrial fibrillation: a Nationwide Cohort Study
    Lehto, Mika
    Luojus, Alex
    Halminen, Olli
    Haukka, Jari
    Putaala, Jukka
    Linna, Miika
    Mustonen, Pirjo
    Kinnunen, Janne
    Lehtonen, Ossi
    Teppo, Konsta
    Tiili, Paula
    Kouki, Elis
    Itainen-Stromberg, Saga
    Niemi, Mikko
    Aro, Aapo L.
    Hartikainen, Juha
    Airaksinen, K. E. Juhani
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [6] Risk of Stroke and Bleeding in Atrial Fibrillation Treated with Apixaban Compared with Warfarin
    Bradley, Marie
    Welch, Emily C.
    Eworuke, Efe
    Graham, David J.
    Zhang, Rongmei
    Huang, Ting-Ying
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (12) : 3597 - 3604
  • [7] Risk of Stroke and Bleeding in Atrial Fibrillation Treated with Apixaban Compared with Warfarin
    Marie Bradley
    Emily C. Welch
    Efe Eworuke
    David J. Graham
    Rongmei Zhang
    Ting-Ying Huang
    Journal of General Internal Medicine, 2020, 35 : 3597 - 3604
  • [8] Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
    Halvorsen, Sigrun
    Atar, Dan
    Yang, Hongqiu
    De Caterina, Raffaele
    Erol, Cetin
    Garcia, David
    Granger, Christopher B.
    Hanna, Michael
    Held, Claes
    Husted, Steen
    Hylek, Elaine M.
    Jansky, Petr
    Lopes, Renato D.
    Ruzyllo, Witold
    Thomas, Laine
    Wallentin, Lars
    EUROPEAN HEART JOURNAL, 2014, 35 (28) : 1864 - 1872
  • [9] Development of apixaban: a novel anticoagulant for prevention of stroke in patients with atrial fibrillation
    Hanna, Michael S.
    Mohan, Puneet
    Knabb, Robert
    Gupta, Elora
    Frost, Charles
    Lawrence, John H.
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALISTS FOR THE PRIX GALIEN USA AWARDS 2013, 2014, 1329 : 93 - 106
  • [10] New Anticoagulants (Dabigatran, Apixaban, Rivaroxaban) for Stroke Prevention in Atrial Fibrillation
    Aguilar, Maria I.
    Kuo, Ruth S.
    Freeman, William D.
    NEUROLOGIC CLINICS, 2013, 31 (03) : 659 - +
12345